Umair Javed
About Umair Javed
Umair Javed is a Scientist I in Medicinal Chemistry at Wave Life Sciences, specializing in Antisense Oligonucleotide therapies for central nervous system disorders. He has a strong background in bioconjugate chemistry and expertise in chromatography and spectrophotometric methods.
Work at Wave Life Sciences
Umair Javed serves as Scientist I in Medicinal Chemistry at Wave Life Sciences, a position he has held since 2021. His role focuses on the development of Antisense Oligonucleotide (ASO) therapies aimed at treating central nervous system (CNS) disorders. He is involved in various drug discovery programs, leveraging his expertise in bioconjugate chemistry to contribute to innovative therapeutic solutions.
Education and Expertise
Umair Javed holds a Master of Science degree in Chemistry with a focus on Total Synthesis from the University of Massachusetts Dartmouth, where he studied from 2014 to 2016. Prior to that, he earned a Master of Science in Pharmacy with a specialization in Medicinal Chemistry from Yeungnam University, studying from 2012 to 2014. He also completed his Pharm-D at the University of Peshawar from 2005 to 2010, providing him with a comprehensive foundation in pharmaceutical sciences.
Background in Medicinal Chemistry
Umair Javed has a strong background in medicinal chemistry, particularly in the area of bioconjugate chemistry. His experience includes working on drug discovery programs that focus on developing therapies for CNS disorders. He specializes in multi-mode chromatography and spectrophotometric methods, which are essential techniques in the analysis and development of pharmaceutical compounds.
Specialization in Antisense Oligonucleotide Therapies
Umair Javed specializes in Antisense Oligonucleotide (ASO) therapies, which are designed to target and modify gene expression in the treatment of central nervous system disorders. His work in this area reflects a commitment to advancing therapeutic strategies that address complex neurological conditions.